New York, United States, Sept. 14, 2024 (GLOBE NEWSWIRE) -- The Global Gallium Arsenide (GaAs) Wafer Market Size is to Grow ...

Infineon has revolutionized GaN wafer production by introducing 300mm wafers, promising increased chip yield, lower costs, ...

In a medical breakthrough, scientists were able to kill 99 per cent of bone cancer cells without causing any harm to the ...

Lab tests have found that bioactive glasses doped with the gallium have a 99% success rate of eliminating cancerous cells and ...

Infineon will shape the rapidly growing GaN market with this groundbreaking GaN 300 mm technology Infineon leverages existing ...

Bioactive glasses, a filling material which can bond to tissue and improve the strength of bones and teeth, has been combined with gallium to create a potential treatment for bone cancer.

Infineon Austria can produce gallium nitride wafers in an existing, scalable high-volume production facility. As the first.

Researchers have developed a potential breakthrough treatment for osteosarcoma, the most common form of bone cancer. Learn ...

Peter Milios is a recent graduate from the University of Technology - majoring in Finance and Accounting. Peter is currently ...

Infineon is leveraging well-established competence in the existing production of 300 mm silicon and 200 mm GaN.

A team of researchers at Aston University have combined bioactive glasses with gallium to create a potential treatment for ...

After 10 days, cancer cells exposed to media conditioned with 10 mg/mL of 4 and 5% gallium-doped glass showed decreased cell ...